Showing results (1661-1670 of 3,235) with videos related to

Sort By:
Pageof 324
Journal of Neurosurgery|December 1, 1986
Intraspinal lipomas with spina bifida. Prognosis and treatment in 73 casesA Pierre-Kahn, J Lacombe, J Pichon, et al.
Cytometry|November 30, 1999
Synthesis of Bcl-2 in response to anthracycline treatment may contribute to an apoptosis-resistant phenotype in leukemic cell linesF Durrieu, M A Belaud-Rotureau, F Lacombe, et al.
Genetic Counseling (Geneva, Switzerland)|April 7, 1999
Abdominal lymphatic dysplasia and 22q11 microdeletionT Mansir, D Lacombe, T Lamireau, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|March 15, 2011
[Polymorphic expression of epilepsy and cognitive impairment in ring chromosome 20 syndrome]F Villéga, H Ngayap, C Espil-Taris, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 9, 2011
Reduction of fibrogenesis by selective delivery of a Rho kinase inhibitor to hepatic stellate cells in miceM M van Beuge, J Prakash, M Lacombe, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 26, 2011
Glomerulonephritis with isolated C3 deposits and monoclonal gammopathy: a fortuitous association?Frank Bridoux, Estelle Desport, Véronique Frémeaux-Bacchi, et al.
Cardiovascular and Interventional Radiology|June 26, 1999
Brain "embolism" detected by magnetic resonance imaging during percutaneous mitral balloon commissurotomyP Rocha, S D Qanadli, P Strumza, et al.
The American Journal of Pathology|July 8, 1999
Deletions of the INK4A gene in superficial bladder tumors. Association with recurrenceI Orlow, H LaRue, I Osman, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 14, 2002
High sensitivity of protoplasmic cortical astroglia to focal ischemiaAnne-Claire Lukaszevicz, Nathalie Sampaïo, Christelle Guégan, et al.
European Journal of Cancer (Oxford, England : 1990)|December 13, 2005
A study from the EORTC new drug development group: open label phase II study of sabarubicin (MEN-10755) in patients with progressive hormone refractory prostate cancerW Fiedler, N Tchen, J Bloch, et al.
Pageof 324